Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Change in Working Capital Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Change in Working Capital
AU$2.1m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Change in Working Capital
-AU$2.7m
CAGR 3-Years
51%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Change in Working Capital
AU$6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Change in Working Capital
AU$75.7k
CAGR 3-Years
-78%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Change in Working Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Change in Working Capital
AU$982k
CAGR 3-Years
69%
CAGR 5-Years
47%
CAGR 10-Years
20%

See Also

What is Arovella Therapeutics Ltd's Change in Working Capital?
Change in Working Capital
2.1m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Change in Working Capital amounts to 2.1m AUD.

What is Arovella Therapeutics Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
22%

Over the last year, the Change in Working Capital growth was 92%. The average annual Change in Working Capital growth rates for Arovella Therapeutics Ltd have been 23% over the past three years , 22% over the past five years .

Back to Top